Lumira Ventures partners with exceptional entrepreneurs to build life science companies that transform the lives of patients worldwide.

Lumira News

Edesa Biotech Reports Quarterly Financial Results

August 14, 2019
Related Article: Edesa Biotech Receives Approval to Proceed with U.S. Clinical Study TORONTO, ON / ACCESSWIRE / August 14, 2019 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage... Learn More

Bardy Diagnostics™ Selected As 1 of 6 Disruptive MedTech Startups for the HealthTech Arkansas Accelerator Program

August 9, 2019
Related Article: Bardy Diagnostics™ Selected as 1 of 50 Leading Startups in the 2019 MedTech Innovator Showcase Program SEATTLE, Aug. 9, 2019 /PRNewswire/ -- Bardy Diagnostics, Inc.,... Learn More

FDA Grants G1 Therapeutics Breakthrough Therapy Designation in Q2 2019 Corporate and Financial Update

August 8, 2019
Related Article: G1 Therapeutics Provides First Quarter 2019 Corporate and Financial Update RESEARCH TRIANGLE PARK, N.C., Aug. 07, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics,... Learn More

Aurinia Releases Q2 2019 Financial Results

August 6, 2019
Related Article: Aurinia Reports First Quarter 2019 Financial Results & Recent Operational Highlights Review condensed consolidated financials here:... Learn More

Team Lumira

Our investment team of 9 professionals has over 225 years of collective experience founding, managing and investing in healthcare and life sciences companies. We value collaboration, creativity and challenging conventional wisdom.



Lumira donates a portion of partner time and profits to support the research, translational medicine and healthcare access missions of over a dozen leading healthcare foundations.

  • “Lumira’s philanthropic vision of leveraging research, resources and knowledge to improve the lives of patients will strengthen St. Michael’s ability to accelerate the pace.”

    Dr. Arthur Slutsky | Vice-President
    Vice-President of Research at St. Michael’s Hospital
  • “Lumira’s model provides a new pathway for philanthropy to partner with investors in advancing healthcare innovation.”

    Barbara Grantham | President & Ceo
    VGH & UBC Hospital Foundation
  • “This distinctive approach to supporting innovation is very creative, very much needed and very much appreciated by Princess Margaret and University Health Network.”

    Paul Alofs | President & Ceo
    Princess Margaret Cancer Foundation

Contact Us

Our team is strategically situated across North America to identify innovative companies within and outside the traditional start-up hubs, and help them access capital, talent and strategic partners.



141 Adelaide Street
Suite 770
Toronto, ON
Canada, M5H 3L5



Espace CDPQ
3, Place Ville Marie
Bureau 12350, Niveau L
Montreal, QC
Canada, H3B 0E7



1021 West Hastings Street,
9th floor
Vancouver, BC
Canada, V6E 0C3



303 Wyman Street
Suite 300
Waltham, MA,
USA, 02451-1208